in US Market 2k1b5m

Business

Dr. Reddy’s Laboratories announces the launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation) in the U.S. Market 6a5y3f

Praveen Comments Off on Dr. Reddy’s Laboratories announces the launch of Testosterone Gel, 1.62% (20.25 mg/1.25 g pump actuation) in the U.S. Market

Dr. Reddy’s Laboratories Ltd. (BSE: 500124, NSE: DRREDDY, NYSE: RDY, along with its subsidiaries together referred to as “Dr. Reddy’s”) today announced the launch of Testosterone Gel 1.62%, a therapeutic equivalent generic version of AndroGel® […]